Summary A trial of the sedative effects of a novel benzodiazepine, climazolam, and of a mixture of c1imazolam and fentanyl-fluanisone was undertaken in male and female Sprague Dawley and Lewis strain rats (Rattus norvegicus) of different ages. At the recommended intravenous therapeutic dosage of 0·25 mg/kg, c1imazolam sedated the rats but failed to inhibit the righting reflex or responses to painful stimuli. Even at 25 times the recommended dosage, there was no anaesthetic effect. Predictable and satisfactory surgical anaesthesia was not obtained with the mixture of c1imazolam and fentanyl-fluanisone administered intra peritoneally. In contrast with diazepam and midazolam, c1imazolam failed to potentiate the sedative analgesic properties of fentanylfluanisone: indeed many animals retained their tail and pedal pinch reflexes. The results also revealed significant differences in effect related to strain and age but not to sex.
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Climazolam (Roche R021-3982) is a recently developed benzodiazepine that is reported to have very quick acting and potent sedative effects in cattle and domestic pigs and is useful in combination with ketamine, ketaminexylazine or etorphine in a variety of zoological species (Gutzwiller, Vollm & Hamza, 1984) . Unlike diazepam, it is water soluble and miscible with other agents such as the neuroleptanalgesic combination fentanylfluanisone (Hypnorm®: Janssen Pharmaceuticals, Beerse, Belgium). Benzodiazepines have been used for many years in conjunction with fentanyl-fluanisone or ketamine at this Centre because they provide excellent muscular relaxation, they potentiate the analgesicsedative properties of fentanyl-fluanisone and they provide safer surgical anaesthesia than barbiturates in rabbits and most but not all species of rodent (Green, 1975; Green et al., 1981; Flecknell & Green, 1982) . Following successful trials (Flecknell & Mitchell, 1984) , a mixture of another water-soluble benzodiazepine midazolam with fentanyl-fluanisone has been used in this laboratory as a satisfactory injectable general anaesthetic in rodents and rabbits. This study was undertaken to compare c1imazolam with midazolam, both as a sedative and as an adjunct to fentanyl-fluanisone neuroleptanalgesia. It was decided to evaluate the drug administered either alone by different routes or together with fentanyl-fluanisone as a single intraperitoneal injection in rats. We looked specifically for the level of sedation obtained with c1imazolam alone, for synergism between the different drugs and for differences in action related to strain, age or sex of the animals.
Materials and methods
Agents Climazolam (Roche, Welwyn Garden City, Herts) was supplied in a 12·5 mg/ml solution and, for the purposes of the present study, this was diluted to 0·125 mg/m\. Fentanyl-fluanisone (Hypnorm®: Janssen Pharmaceuticals) consists of fentanyl citrate at 0·315 mg/ml and fluanisone at 10 mgtml. At these concentrations cIimazolam was found to be directly miscible and the pharmacological activity of the mixture was as high at the end of 6 weeks as at the beginning of the trials.
Animals
All rats were entered into the trials directly after issue from the barrier-maintained breeding unit to avoid any possibility of variation in their health status. They were anaesthetized at the same time of day to avoid variations attributable to circadian rhythms or blood glucose levels.
Experimental protocol
In pilot experiments, the sedative effects of cIimazolam alone were evaluated in rats after administration by the intraperitoneal, intramuscular and subcutaneous routes. After these trials, experiments were carried out to study the sedation produced by a range of dosages of cIimazolam alone either as a single intravenous or intraperitoneal injection or when given repeatedly by the intraperitoneal route. To study the sedative effects of increasingly high intravenous dosages of cIimazolam, 0·065, 0·120, 0·25 and 1-0 mgtkg were injected into the tail vein of five adult male Lewis rats (group 1). In group 2, five adult male Sprague Dawley (SD) rats (mean weight, 300 g) were injected intra peritoneally with cIimazolam at 2·5 mg/kg (10 times the manufacturer's recom-mended dosage for rodents) on days 0, 7 and 14. In group 3, five adult male Lewis rats (mean weight, 250 g) were injected once intraperitoneally with climazolam at 6·25 mgt kg (25 times the recommended dosage). In the second set of experiments, the sedative or anaesthetic effects of a combination of cIimazolam with fentanyl-fluanisone were evaluated. Climazolam was used at two different dosages with the same dosage of fentanylfluanisone (Table 1) . Ten SD rats, five of each sex, and 10 Lewis rats, five of each sex (aver~g~age of both strains, 7·0 weeks), were allocated to groups 4 and 5 respectively _ In groups 6 and 7, 10 SD rats and 10 Lewis rats of average age 7·0 weeks were given a single intraperitoneal injection with cIimazolam at a higher dosage. In groups 8 and 9, similar numbers of rats were allocated but the average age was 9·0 weeks and the dosage of cIimazolam was the same as in groups 4 and 5. Each rat was injected intraperitoneally with a single injection containing the calculated dose of fentanyl-fluanisone and cIimazolam. Anaesthetic potency of the combinations was assessed by loss of the righting reflex, loss of the tail pinch reflex and loss of the pedal withdrawal reflex and the times taken for their loss and then return during recovery. The respiratory rate was noted at the time the righting reflex was lost.
Statistical analysis
The results of the anaesthetic trial in groups 8 9 "The same dosage of fentanyl-nuanisone (0·3 ml/kg) was given in the single intraperitoneal injection to all groups of animals. Sedativeeffectsof c1imazolamin rats 4-9 inclusive were analysed in two ways. First, the four interacting factors of strain, sex, age and dosage were subjected to unbalanced analysis of variance using a generalized linear interactive modelling programme. Secondly, an unbalanced analysis of variance was performed to compare the times in minutes in which the different reflexes were lost.
Results
In the pilot studies, climazolam alone at the recommended dosage for rodents (0,25 mg/kg) proved an effective sedative in rats and, as expected, the full effect developed more quickly after intramuscular and intraperitoneal injection than when administered by the subcutaneous route. The rats became ataxic and drowsy but did not lose their righting reflex. Increased dosage simply extended the time over which they returned to normal and did not increase the level of sedation.
Since deep sedation bordering on anaesthesia can be induced by intravenous administration of diazepam in some species, it was decided to evaluate climazolam alone at five different dose rates by this route (group 1). However, even at 1·0 mg/kg intravenously (4 times the recommended dose rate), the righting reflex was not lost and no analgesic effect developed, although the onset of sedative and muscle relaxant action was more rapid and the effects lasted longer. No adverse effects were encountered. In group 2, no adverse side effects were observed in the rats after three intraperitoneal injections of climazolam had been given at weekly intervals but again the drug had no analgesic effect even at 10 times the recommended dosage. Similarly, there was no evidence of toxicity in the rats in group 3 examined after a high single dose of climazolam (6·25 mg/kg) had been administered intraperitoneally but, even at this dosage (25 times the recommended dose), no analgesia was produced and the loss of righting reflex was transient.
The results of the anaesthetic trial with the combination of climazolam and fentanyl-145 fluanisone are summarized in Table 2 . Even in SD rats where it was most effective, many of the animals did not lose their pedal withdrawal reflex and some even retained their righting reflex. In fact, the responses of the animals were so unpredictable that it proved difficult to draw statistically significant conclusions at all. However, in a comparison of time taken to loss of righting reflex, there was a significant effect of age with both the proportion of animals losing the reflex lower and the time taken to lose it longer in the older groups (P < 0·004).
There were also significant differences in the way the two strains were affected by the increased dose of climazolam (P < 0·003). It was noticeable that doubling the dosage made little difference to the time taken to lose the righting reflex in the SD rats whereas it nearly halved it in the Lewis strain.
All the rats lost their response to tail pinch before the pedal withdrawal reflex. The influence of strain was again significant (P < 0·03) in that more SD rats lost the reflex than Lewis rats did but the latter lost it for longer if it disappeared at all. As might be expected, fewer animals lost their tail pinch reflex than their righting reflex for both strains of rat. Finally, too few animals reached a depth of anaesthesia for loss of pedal withdrawal reflex to make any comparison between groups meaningful.
Discussion
The results of these trials provide further evidence for the marked strain and age differences seen in response to all injectable central nervous system depressants and indicate that climazolam is an excellent sedative in rats. It has the advantage over diazepam that it is water soluble, and effective dosages can be given in very small volumes. Its central muscle relaxant properties are similar to those of diazepam and midazolam. Injection by whatever route appears to be painless.
It was both disappointing and surprising, however, that climazolam should fail to potentiate fentanyl-fluanisone in this species. ..; '00+'00+'00+'00+'00+'00+ 99 lI"lt'"-I I
Sedative effects of c1imazolam in rats
Indeed, although no strict statistical comparison between the effects of fentanyl-f1uanisone alone and those of the combination with climazolam was made, clinical observation clearly indicated that rats given the combination were less deeply anaesthetized than those given fentanyl-f1uanisone at the same dosage. This is in such marked contrast with previous experience in rats with the fentanyl-f1uanisone-diazepam combination (Green, 1975 (Green, , 1979 and fentanyl-f1uanisone-midazolam (Fleck nell & Mitchell, 1984) that it suggests that climazolam actually antagonizes or partially antagonizes the potent sedativeanalgesic properties of fentanyl-f1uanisone. There are several possible reasons for this apparent contrast. Incompatibility of a mixture of drugs is of course no new phenomenon and can be due for example to precipitation of one of the active agents in the solution, to different absorption from the injection site, to accelerated metabolism in the body in response to two agents or to competition for receptor sites in the central nervous system. The best known (but not the only) mechanism of action of benzodiazepines is specific enhancement of GABA-ergic transmission across synaptic junctions, and hence, as GABA is the most abundant inhibitor of neurotransmission in the brain, benzodiazepines act as general depressants of central nervous system activity. The intensity of this depressive effect is limited by the fact that benzodiazepines probably act indirectly to close chloride channels via a limited number of specific benzodiazepine receptors (Bonetti et al., 1982) . In the present experiments', climazolam alone proved to be as good a sedative as diazepam and midazolam. We therefore attempted to show that the failure of the combination was due to incompatibility of the agents in solution and injected fentanyl-f1uanisone separately from climazolam at different intraperitoneal sites; however, the resultant anaesthetic effect was no better than before. Hence it seems possible that, unlike diazepam and midazolam, climazolam (or one of its metabolites) competes in the central nervous system for morphine-type receptors, at least in this species.
From these preliminary trials in rats it seems likely that climazolam alone will prove valuable in several species used in biomedical research, e.g. in rabbits and ferrets. Its potency (and hence the low volumes needed for injection) indicates that it will be useful in combination with ketamine for chemical restraint of pigs. Its wide therapeutic margin, lack of effect on cardiovascular and pulmonary functions and its central muscle relaxant effects suggest that it may provide an excellent alternative to xylazine in many situations where it is important that cardiovascular function is stable for the duration of an experiment.
